Related Experiment Video
Updated: Jun 18, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Age-related blood transcriptional regulators affect disease progression in pediatric multiple sclerosis
Eitan Shavit1, Shay Menascu2, Anat Achiron2
1Multiple Sclerosis Center, Sheba Medical Center, Ramat-Gan, Israel; St. George's Hospital Medical School, University of London, London, United Kingdom; Arrow project for medical research education, Sheba Medical Center, Ramat-Gan, Israel.
Insights
Pediatric onset multiple sclerosis (POMS) exhibits more severe disease activity than adult onset multiple sclerosis (AOMS). Gene expression analysis reveals distinct molecular mechanisms, including cell cycle and B lymphocyte pathways, contributing to POMS severity.
Area of Science:
- Neuroimmunology
- Genomics
- Pediatric Neurology
Background:
- Pediatric onset multiple sclerosis (POMS) is defined as multiple sclerosis with onset before age 18.
- POMS patients often present with more severe disease activity compared to adult onset multiple sclerosis (AOMS) patients.
- The molecular mechanisms underlying these clinical differences remain largely unknown.
Purpose of the Study:
- To investigate the molecular differences in gene expression between POMS and AOMS.
- To identify potential molecular mechanisms contributing to the distinct clinical presentations of POMS.
- To explore the relationship between gene expression patterns and disease severity in POMS.
Main Methods:
- Gene expression analysis of Peripheral Blood Mononuclear Cells (PBMCs) from 22 POMS and 16 AOMS patients using Affymetrix microarrays.
- Identification of Differentially Expressed Genes (DEGs) between POMS and AOMS using Partek software.
- Clinical assessment via Expanded Disability Status Scale (EDSS) and brain MRI lesion load, with functional analysis by Ingenuity Pathway Analysis.
Main Results:
- POMS patients showed higher EDSS scores and greater T1 and T2 brain MRI lesion volumes compared to AOMS patients.
- A total of 551 DEGs were identified in POMS, enriched in cell cycling, B lymphocyte signaling, and senescence pathways.
- 183 DEGs correlated with T2 lesion volume, and 29 common DEGs between POMS age-related regulators and healthy subjects suggested a role in disease severity.
Conclusions:
- Higher transcriptional levels of genes in cell cycle, cell migration, and B cell proliferation pathways are associated with POMS.
- Age-associated genes and transcription factors appear to promote these pathways in POMS.
- These molecular findings provide a better understanding of the aggressive clinical course observed in pediatric onset multiple sclerosis.
Background:
Pediatric onset multiple sclerosis patients (POMS) are defined as multiple sclerosis with an onset before the age of 18 years. Compared to adult onset multiple sclerosis (AOMS), POMS has more severe disease activity at onset, but better recovery. Little is known about the molecular mechanism responsible for the differences in the clinical presentations.
Methods:
Peripheral Blood Mononuclear Cells samples were taken from 22 POMS patients (mean age 14.1 ± 2.4 years, 15 females, 7 male), and 16 AOMS patients, (mean age 30.8 ± 6.1 years,10 females, 6 males), and gene-expression were analyzed using Affymetrix Inc. HU-133-A2 microarrays. Differentially Expressed Genes (DEGs) that significantly distinguished between POMS and AOMS with pvalue <0.05 after false discovery rate correction were evaluated using Partek software. Twenty-one matched age and gender control was applied to clarify age-related changes. Clinical assessment was performed by analysis of expanded disability status scale (EDSS) and brain MRI lesion loads. Gene functional analysis was performed by Ingenuity Pathway Analysis software.
Results:
Compared to AOMS, POMS had higher EDSS (3.0 IQR 2.0-3.0 and 2.0 IQR 2.0-3.0, p = 0.005), volume of T1 (2.72 mm3, IQR 0.44-8.39 mm3 and 0.5 mm3 IQR 0-1.29 mm3 respectively, p = 0.04) and T2 (3.70 mm3, IQR 1.3-9.6 and 0.96 mm3, IQR 0.24-4.63 respectively, p = 0.02) brain MRI lesions. The POMS transcriptional profile was characterized by 551 DEGs, enriched by cell cycling, B lymphocyte signaling and senescent pathways (p < 0.02). Of these, 183 DEGs significantly correlated with T2 lesions volume. The POMS MRI correlated DEGs (n = 183) and their upstream regulators (n = 718) has overlapped with age related DEGs obtained from healthy subjects (n = 497). This evaluated common DEGs (n = 29) defined as POMS age-related regulators, suggesting to promote effect on disease severity.
Conclusion:
Our finding of higher transcriptional levels of genes involved in cell cycle, cell migration and B cell proliferation that promoted by transcriptional level of age-associated genes and transcription factors allows better understanding of the more aggressive clinical course that defines the POMS.
Related Concept Videos
Transcription Factors
Master Transcription Regulators
General Transcription Factors
iPS Cell Differentiation
Multiple Sclerosis l: Introduction

